Emelie Styring
1 – 10 of 24
      - show: 10
 - |
 - sort: year (new to old)
 
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
 - 
                        Mark
        Low overall survival after treatment for angiosarcoma : a single-centre retrospective observational cohort study of 64 patients
    
    
- Contribution to journal › Article
 
 - 2024
 - 
                        Mark
        CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcoma
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Osteosarcomas With Few Chromosomal Alterations or Adult Onset Are Genetically Heterogeneous
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway
    
    
- Contribution to journal › Article
 
 - 2022
 - 
                        Mark
        Intralesional margin after excision of a high-grade osteosarcoma : Is it a catastrophe?
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Bone mineral : A trojan horse for bone cancers. Efficient mitochondria targeted delivery and tumor eradication with nano hydroxyapatite containing doxorubicin
    
    
- Contribution to journal › Article
 
 - 2021
 - 
                        Mark
        Late Local Recurrence and Metastasis in Soft Tissue Sarcoma of the Extremities and Trunk Wall : Better Outcome After Treatment of Late Events Compared with Early
    
    
- Contribution to journal › Article
 
 - 2020
 - 
                        Mark
        Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma
    
    
- Contribution to journal › Article
 
 - 2019
 - 
                        Mark
        Ewing sarcoma of the mobile spine; predictive factors for survival, neurological function and local control. A Scandinavian sarcoma group study with a mean follow-up of 12 years
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Ökad risk för fettembolisyndrom vid Duchennes muskeldystrofi
    
    
- Contribution to journal › Article
 
 
